Medimmune Vaccines, Inc.

Mountain View, CA 94043

SBIR Award Summary

Total Number of Awards 16
Total Value of Awards $2.52MM
First Award Date 01/01/95
Most Recent Award Date 09/01/02

Key Personnel

Last Name Name Awards Contact
Li Shengqiang Li 1
Kemble George W Kemble 7
Prichard Mark N Prichard 2
Haller Aurelia A Haller 3
Jin Hong Jin 3

16 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/02 - 08/31/03

DESCRIPTION: (Adapted from Applicant's Abstract) Human parainfluenza virus (hPIV) and human respiratory syncytial virus (hRSV) are the main causes of acute respiratory diseases during infancy and early childhood worldwide, often requiring hospitalization. Both viruses are also responsible for serious respira...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 05/31/02 - 05/30/03

DESCRIPTION: (Adapted from Applicant's Abstract) Genital herpes is a major health problem in the U.S. The prevalence of these infections is dramatically increasing despite effective antiviral drugs. This increase puts young adults and infants at risk of genital and neonatal herpes, respectively. Neonatal herpes ...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/30/01 - 08/31/02

DESCRIPTION: (Adapted from Applicant's Abstract) Human parainfluenza virus (hPIV) and human respiratory syncytial virus (hRSV) are the main causes of acute respiratory diseases during infancy and early childhood worldwide, often requiring hospitalization. Both viruses are also responsible for serious respira...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/01 - 08/31/02
PI: Hong Jin

DESCRIPTION: (Adapted from the Applicant's Abstract) Respiratory syncytial virus (RSV), subgroups A and B, is the leading cause of pediatric respiratory tract diseases worldwide. RSV is also responsible for serious respiratory tract infection in the elderly and immunocompromised individuals. No vaccine is current...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 06/01/01 - 05/30/02

DESCRIPTION: (Adapted from Applicant's Abstract) Genital herpes is a major health problem in the U.S. The prevalence of these infections is dramatically increasing despite effective antiviral drugs. This increase puts young adults and infants at risk of genital and neonatal herpes, respectively. Neonatal herpes ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/00 - 08/31/01

Human cytomegalovirus (HCMV) associated disease is responsible for over $10 billion in healthcare costs annually in the US. Mental retardation and hearing impairment caused by congenital CMV infection, and organ transplant rejection and MDS associated CMV retinitis and colitis are preventable diseases. However, no vaccine currently exists for pr...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/00 - 08/31/01
PI: Hong Jin

DESCRIPTION: (Adapted from the Applicant's Abstract) Respiratory syncytial virus (RSV), subgroups A and B, is the leading cause of pediatric respiratory tract diseases worldwide. RSV is also responsible for serious respiratory tract infection in the elderly and immunocompromised individuals. No vaccine is current...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/30/99 - 08/31/00

Human cytomegalovirus (HCMV) associated disease is responsible for over $10 billion in healthcare costs annually in the US. Mental retardation and hearing impairment caused by congenital CMV infection, and organ transplant rejection and MDS associated CMV retinitis and colitis are preventable diseases. However, no vaccine currently exists for pr...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/15/99 - 02/14/00
PI: Hong Jin

DESCRIPTION: (Adapted from Applicant's Abstract) Respiratory Syncytial Virus (RSV), subgroups A and B, are responsible for serious respiratory tract disease in infants, and the elderly and immunocompromised persons. No vaccine is currently available and subunit approaches have so far failed. The investi...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/15/99 - 02/14/00

Bovine parainfluenza type 3 virus (bPIV3) was shown in clinical trials to be safe when administered to small infants and children, and attenuated, causing no lower respiratory disease in children. bPIV3 was genetically stable after replication in children. These three characteristics provide the basis for the use of bPIV3 as an effective vector ...

Load More